Back

The tyrosine kinase inhibitor nilotinib inhibits discoidin domain receptor 2 in human aortic valves, increases aortic valve thickness and induces valvular interstitial cell calcification

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Basic and Translational Science - Atherosclerosis and Aortic Stenosis Cardio-Oncology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Magnus Back

Karolinska University Hospital, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Heat Shock Protein 25 Immunotherapy Post-Menopause is Superior to Estradiol in Targeting Atherogenesis, Plasma Cholesterol and PCSK9 Levels
Professor E. O'Brien (Calgary, CA)
Slides Video
Presentation thumbnail
A novel CT-based radiotranscriptomic signature of perivascular fat improves cardiac risk prediction in the SCOT-HEART and CRISP-CT studies
Professor C. Antoniades (Oxford, GB)
Presentation thumbnail
Clonal hematopoiesis of indeterminate potential (CHIP) in patients with degenerative aortic valve stenosis: incidence, clinical correlates, and prognostic significance following TAVI
Doctor S. Mas-Peiro (Frankfurt, DE)
Slides Video
Presentation thumbnail
Dipeptidyl Peptidase-4 Inhibition to Prevent Calcific Aortic Valve Disease: Proof of Concept Study (DIP CAVD_POC)
Doctor J. Song (Seoul, KR)
Slides Video

Access the full session

Session thumbnail
Late Breaking Basic and Translational Science - Atherosclerosis and Aortic Stenosis

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources